Anticalin® proteins are artifical proteins derived from human lipocalins. They have a diversifiable amino acid sequence that results in four loops. These loops assemble into a cup like structure that can bind both smaller and larger molecules.金沙官网
金沙官网网址
金沙官网
We have a strategic collaboration in respiratory diseases with Pieris Pharmaceuticals, Inc. to develop novel inhaled drugs that leverage Pieris’ Anticalin® platform. Anticalin molecules are engineered proteins which can mimic antibodies by binding to sites either on other proteins or on small molecules. They are smaller than monoclonal antibodies, offering the potential of direct delivery to the lung.
-
金沙官网网址
AstraZeneca is one of the world’s most exciting bio-pharmaceutical companies. Be inspired by the possibilities of science to make a difference and discover what you can do.
-
金沙官网网址
We know that innovation doesn’t happen in isolation, so we partner with others to access the best science and contribute complementary technologies, know-how and molecules.
